Jérôme Harambat

Phase 1/2 Study of Lumasiran for Treatment of Primary Hyperoxaluria Type 1

Yaacov Frishberg, Georges Deschênes, Jaap W. Groothoff et al. · Clinical Journal of the American Society of Nephrology · 2021 · 80 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

Successful treatment with rituximab for acute refractory thrombotic thrombocytopenic purpura related to acquired ADAMTS13 deficiency: A pediatric report and literature review

Jérôme Harambat, Delphine Lamireau, Yahsou Delmas et al. · Pediatric Critical Care Medicine · 2010 · 17 citations

Medicine, Hematology, Pediatrics +15

Improved Outcome of Infantile Oxalosis Over Time in Europe: Data From the OxalEurope Registry

Lisa J. Deesker, Sander F. Garrelfs, Giorgia Mandrile et al. · Kidney International Reports · 2022 · 17 citations · Full text

Medicine, Nephrology, Pediatrics +16

Pediatric ANCA vasculitis: clinical presentation, treatment, and outcomes in a French retrospective study

S A Mahi, Jérôme Harambat, Lise Allard et al. · Pediatric Nephrology · 2023 · 15 citations

Medicine, Clinical Sciences, Pediatrics +11

Disparities in treatment and outcome of kidney replacement therapy in children with comorbidities: an ESPN/ERA Registry study

Raphael Schild, Simeon Dupont, Jérôme Harambat et al. · Clinical Kidney Journal · 2023 · 11 citations · Full text

Medicine, Nephrology, Pediatrics +12